Advertisement

Topics

Liver Cancer Drug Distribution Hitting Goals in Korea

05:35 EDT 24 Aug 2017 | PharmPro

Can-Fite receives milestone payment from CKD Pharmaceuticals, its distribution partner in Korea. It marks the second payment in distribution agreement valued at up to $3M in upfront and milestone payments plus 23 percent royalties on sales.
Contributed Author: 
Can-Fite BioPharma Ltd.
Topics: 

Original Article: Liver Cancer Drug Distribution Hitting Goals in Korea

NEXT ARTICLE

More From BioPortfolio on "Liver Cancer Drug Distribution Hitting Goals in Korea"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...